Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
KSH01 injection
TScan Therapeutics
Solid Tumor
1 trial -
KSH01 injection
TScan Therapeutics
TCR-T Cells
1 trial -
KSV01 Injection
TScan Therapeutics
B-ALL
1 trial -
KSV01 Injection
TScan Therapeutics
Non-Hodgkin Lymphoma
1 trial -
KSX01-TCRT injection
TScan Therapeutics
TCR-T Cells
1 trial -
KXV01 TCR Lentinvivo Injection
TScan Therapeutics
Advanced Solid Tumors
2 trials -
SOC + TSC-100
TScan Therapeutics
AML
1 trial -
TSC-204-A0201
TScan Therapeutics
Head and Neck Cancer
1 trial -
Tcrx T cell
TScan Therapeutics
Gastric Cancer
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources